Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan.
Int J Clin Pharm. 2014 Apr;36(2):405-11. doi: 10.1007/s11096-013-9910-9. Epub 2014 Feb 11.
The incidence and risk factors of amiodarone-induced thyroid dysfunction are variable in the literature.
The aim of this study was to investigate the clinical and biochemical features and risk factors of amiodarone-induced thyroid dysfunction in Taiwan.
This study was conducted at a tertiary referral center for arrhythmia.
Retrospective analysis of patients treated with amiodarone during the years 2008-2009 was performed.
Incidence and risk factors of amiodarone-induced thyrotoxicosis (AIT) and amiodarone-induced hypothyroidism (AIH) were assessed.
Of the 527 patients, 437 (82.9 %) remained euthyroid, 21 (4.0 %) developed AIT, and 69 (13.1 %) were affected with AIH. In univariate analysis, AIT was associated with younger age, and the risk factors for AIH included older age, higher baseline thyroid stimulating hormone (TSH) titer, lower baseline free T4 level, lower cumulative amiodarone dosage, and shorter amiodarone treatment duration. Cox regression analysis was performed to determine the different risk categories in the elderly population of age 65-74 (young-old), 75-84 (old-old), and ≥85 years old (oldest-old). Additionally increased risk of AIH was found in the groups of old-old (HR 2.09, 95 % CI 1.11-3.96) and oldest-old (HR 2.57, 95 % CI 1.21-4.75). In the multivariate analysis of risk factors for AIH, baseline TSH level (HR 1.38, 95 % CI 1.12-1.70) and cumulative amiodarone dosage (HR 0.95, 95 % CI 0.93-0.97) remained statistically significant.
AIH was much more common than AIT in Taiwan, an area with sufficient iodine intake. Higher baseline TSH level was the predominant independent risk factor for the development of AIH.
胺碘酮致甲状腺功能障碍的发病率和危险因素在文献中各不相同。
本研究旨在探讨台湾胺碘酮致甲状腺功能障碍的临床和生化特征及危险因素。
本研究在一家心律失常三级转诊中心进行。
对 2008-2009 年期间接受胺碘酮治疗的患者进行回顾性分析。
评估胺碘酮致甲状腺毒症(AIT)和胺碘酮致甲状腺功能减退症(AIH)的发生率和危险因素。
在 527 例患者中,437 例(82.9%)保持甲状腺功能正常,21 例(4.0%)发生 AIT,69 例(13.1%)发生 AIH。单因素分析显示,AIT 与年龄较小有关,AIH 的危险因素包括年龄较大、基线促甲状腺激素(TSH)水平较高、游离 T4 水平较低、累积胺碘酮剂量较低和胺碘酮治疗时间较短。进行 Cox 回归分析以确定 65-74 岁(年轻老年人)、75-84 岁(老年人)和≥85 岁(最老年人)老年人中的不同危险类别。此外,在老年人(HR 2.09,95%CI 1.11-3.96)和最老年人(HR 2.57,95%CI 1.21-4.75)组中发现 AIH 的风险增加。在 AIH 的多因素危险因素分析中,基线 TSH 水平(HR 1.38,95%CI 1.12-1.70)和累积胺碘酮剂量(HR 0.95,95%CI 0.93-0.97)仍具有统计学意义。
在碘摄入充足的台湾地区,AIH 比 AIT 更为常见。较高的基线 TSH 水平是 AIH 发生的主要独立危险因素。